RxDoctor Payments Data

Heidi Yutzler-Overton, DO

Family Medicine · Blue Bell, PANPI 1730133869

Payments from drug & device makers

$840in general payments, 2019–2025

Across 36 payments — averaging $23.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$167
  • AbbVie$125
  • Pfizer$115
  • Shield Therapeutics Inc$79
  • Abbott$77
  • Lilly USA, LLC$45
  • plus $233 from 10 others

What the payments were for

  • Food & beverage$840100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$840 in reported general payments places this provider in the 65th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$126,833
Medicare patients
432
Services billed
1,156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin80$79,547
EliquisApixaban65$66,794
TrulicityDulaglutide37$43,586
JanuviaSitagliptin Phosphate28$28,748
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$17,256
MyrbetriqMirabegron20$16,362
Breo ElliptaFluticasone/Vilanterol41$16,041
OzempicSemaglutide17$15,498
XanaxAlprazolam14$12,005
SynthroidLevothyroxine Sodium124$9,397
Dexlansoprazole DrDexlansoprazole16$7,060
TradjentaLinagliptin11$6,520
Janumet XrSitagliptin Phos/Metformin Hcl11$6,219
Rosuvastatin Calcium265$4,571
Atorvastatin Calcium349$3,518

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$115$66,79465 claims
Lilly USA, LLCTrulicity$45$43,58637 claims
MerckJanuvia, Janumet Xr$14$34,96839 claims
Novo NordiskOzempic$167$15,49817 claims
AbbVieSynthroid$125$9,397124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Blue Bell

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →